Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Uncovering the Molecular Underpinnings of Inflammation
Scientific Advances

Uncovering the Molecular Underpinnings of Inflammation

By Olivia DimmerAug 30, 2023
Share
Facebook Twitter Email
William A. Muller, MD, PhD, the Janardan K. Reddy, MD Professor of Pathology, was senior author of the study published in Immunity.

Northwestern Medicine investigators have identified new molecular details regarding how white blood cells move across the walls of microvessels during inflammation, revealing new potential molecular targets for treating the condition, according to a new study published in the journal Immunity.

Chronic inflammatory diseases are the most significant cause of death in the world, according to the World Health Organization (WHO), which ranks chronic diseases as the greatest current threat to human health. Inflammation is a key component of many of those diseases, including asthma, heart disorders and obesity, and the number of people experiencing a disease associated with chronic inflammation is expected to increase in the U.S. over the next several decades.

Diapedesis, the passing of blood cells across the walls of the microvasculature, is a hallmark of inflammation that is not currently well understood, said William A. Muller, MD, PhD, the Janardan K. Reddy, MD Professor of Pathology and senior author of the study.

“Most diseases are due to inflammation that’s in the wrong place at the wrong time, or is out of control,” said Muller, who is also a member of the Robert H. Lurie Comprehensive Cancer Center and the Center for Human Immunobiology of Northwestern University. “Evolutionarily, inflammation is a good thing because it heals wounds and keeps us free of bacteria, but now that we have evolved to the point where we’re no longer dying of infectious diseases, we’re living long enough to see the parts of inflammation that have never been selected out in nature. All the good, the bad, and the ugly of inflammation takes place after white blood cells, or leukocytes, cross out of the bloodstream into the tissues.”

In the current study, Muller and his collaborators used fluorescence lifetime imaging microscopy to track white blood cells in cultured tissues as they interacted with platelet endothelial cell adhesion molecule 1, or PECAM-1, a molecule known to be involved in the migration of blood cells through capillary walls.

The white blood cells used physical traction to “pull” on PECAM-1 and initiate the migration, according to the study.

The force applied to PECAM-1 activated a series of other molecules, including vascular endothelial growth factor receptor 2 (VEGFR2), according to the study.

To test whether VEGFR2 was essential for the migration process, the investigators then bred mice that lacked VEGFR2 in adult endothelial cells and found that the absence of VEGFR2 significantly reduced diapedesis, and therefore inflammation.

The findings add to our understanding of diapedesis and provide new potential targets for controlling inflammation, Muller said.

“The significance of these findings is twofold: One is that it shows that the physical force of the PECAM on endothelial cells is what initiates transmigration,” Muller said. “And the second is that VEGFR2 had never been suggested to be involved in transmigration before. This gives us another molecular target for hopefully blocking inflammation.”

Future work in the Muller lab will focus on understanding the other key molecular players involved in diapedesis and identifying inhibitors for inflammatory processes, Muller said.

“Blocking diapedesis by targeting these processes that occur uniquely within the endothelial cells during transmigration only blocks leukocyte recruitment by 80 to 90 percent. However, that may be a good thing. These interventions have no effect on our body’s ability to sense or respond to new inflammatory insults — or for the 10 to 20 percent of leukocytes that do transmigrate to perform their necessary functions. In people with normal white blood cell counts, this fraction is probably enough to keep us healthy,” Muller said.

This approach would still allow the body to fight bacteria and heal wounds, but could potentially reduce the symptoms of conditions such as inflammatory bowel disease or psoriasis, Muller said.

Tao Fu, MD, PhD, research assistant professor of Pathology, and David Sullivan, PhD, research associate professor of Pathology, were co-authors of the study.

The study was supported by the Sidney & Bess Eisenberg Memorial Fund and by National Institutes of Health grants F31 HL131355, F30 HL134202, R01 HL064774, R01 HL046849 and R35 HL155652.

Cancer Pathology Research
Share. Facebook Twitter Email

Related Posts

Mapping Neural Activity Patterns and Odor Perception  

Sep 28, 2023

Small, Implantable Device Could Sense and Treat Cancer

Sep 26, 2023

Gene Linked to Glioblastoma Stem Cell Self-Renewal and Immunosuppression

Sep 26, 2023

Comments are closed.

Latest News

Mapping Neural Activity Patterns and Odor Perception  

Sep 28, 2023

Lloyd-Jones Announces He is Stepping Down as Chair of Preventive Medicine

Sep 27, 2023

Small, Implantable Device Could Sense and Treat Cancer

Sep 26, 2023

Gene Linked to Glioblastoma Stem Cell Self-Renewal and Immunosuppression

Sep 26, 2023

Northwestern Simulation’s In Situ Training Tests Cardiac Arrest Response Teams

Sep 25, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230914_NM461
20230914_NM644
20230914_NM345
20230914_NM444
20230914_NM464
20230914_NM520
20230914_NM673
20230914_NM641
20230914_NM612
20230914_NM608
20230914_NM602
20230914_NM597

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.